Narcolepsy Market Current And Future Industry Trends by 2027 narcolapsy | Page 4

Global Coconut Milk Products Market to 2027
www.theinsightpartners.com
Request Sample Copy of this report at
https://www.theinsightpartners.com/sample/TIPRE00003326/
The global narcolepsy market on the basis of product is segmented into sodium oxybate, central nervous system
(CNS) stimulants, and antidepressants. Sodium oxybate segment is anticipated to grow at a CAGR of 9.8% during
the forecast period. Sodium oxybate is the one of the primary medication recommended by specialists to patients
suffering with narcolepsy. The high cost of the branded counterparts, availability of reimbursement with certain
regions as well as approval of the drug in majority of the top markets is likely to contribute to the growth and
dominance of the segment. Sodium is oxybate is also expected to exhibit highest growth witnessing a robust CAGR
over the forecast years.
Some of the prominent players operating in narcolepsy market are Bioprojet, Teva Pharmaceutical Industries Ltd.,
Jazz Pharmaceuticals, Inc., Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., Shire (Acquired by Takeda),
Ligand Pharmaceuticals, Inc., Novartis AG, Mylan N.V., and Shionogi Inc. The market players are focused towards
bringing new and innovative products and services to sustain their position in the market.
Rising prevalence of sleep related neurological disorders is driving the market for narcolepsy over
the forecast period.
4